Skip to main content
Watch Insiders
KLRS filings

Corporate insider profile

Srinivas Akkaraju Filing Activity

Latest reported as Director / 10% Owner of Kalaris Therapeutics, Inc. (KLRS).

Purchase filings
1
Reported companies
1
Net open-market value
$1,179,969
Latest transaction
May 20, 2026

Affiliated corporations

Reported company relationships

KLRSLatest reported

Kalaris Therapeutics, Inc.

Director / 10% Owner

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 20, 2026Kalaris Therapeutics, Inc. (KLRS)Director / 10% OwnerOpen Market Purchase244,300$4.83$1,179,969